Brief: Repare Therapeutics Provides Business Update And Reports Second Quarter 2021 Financial Results
Aug 12 (Reuters) - Repare Therapeutics Inc RPTX.O :
* REPARE THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
SECOND
QUARTER 2021 FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.71
* Q2 EARNINGS PER SHARE ESTIMATE $-0.61 -- REFINITIV IBES
DATA
* PLANNING DISCLOSURE OF INITIAL MONOTHERAPY DATA FROM PHASE
1/2
TRESR RP-3500 CLINICAL TRIAL EARLY IN 4Q21
* REPARE THERAPEUTICS - CASH, EQUIVALENTS, AS OF JUNE 30,
2021
WERE $301.0 MILLION
Source text for Eikon: ID:nBwCDMZQa
Further company coverage: RPTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Repare Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Repare Therapeutics Announces Acquisition Of Polθ ATPase Inhibitor, RP-3467, By Gilead Sciences For Up To $30 Million In Total Consideration
Brief: Repare Signs Support Agreements With Key Shareholders For Xenotherapeutics Deal
Repare Therapeutics Q2 net loss narrows to $16.7 mln